Abstract
Background: The blood in the umbilical cord that provides the connection between mother and fetus during pregnancy is called cord blood. The blood of umbilical cord which is usually got rid of following birth, is a very rich stem cell source.
Objective: Cord blood collection gives no harm to the mother and baby. Besides, its allogeneic and autologous usage, the most important disadvantage is that the number of cells is insufficient in adults.
Conclusion: Today, it is predominantly used for therapeutic purposes for many diseases. The aim of this review is giving a detailed information about groups of stem cells in cord blood and determining the point of clinical use.
Keywords: Clinical use, cord blood, stem cell, umblical cord blood, patent, haematology, haemopoetic diseases.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title:Clinical Use and Patentability of Cord Blood
Volume: 11 Issue: 1
Author(s): Turker Cavusoglu*, Kubilay Dogan Kilic, Gurkan Yigitturk, Canberk Tomruk, Mehmet Turgut and Yigit Uyanikgil
Affiliation:
- Department of Histology and Embryology, Ege University School of Medicine, Izmir,Turkey
Keywords: Clinical use, cord blood, stem cell, umblical cord blood, patent, haematology, haemopoetic diseases.
Abstract: Background: The blood in the umbilical cord that provides the connection between mother and fetus during pregnancy is called cord blood. The blood of umbilical cord which is usually got rid of following birth, is a very rich stem cell source.
Objective: Cord blood collection gives no harm to the mother and baby. Besides, its allogeneic and autologous usage, the most important disadvantage is that the number of cells is insufficient in adults.
Conclusion: Today, it is predominantly used for therapeutic purposes for many diseases. The aim of this review is giving a detailed information about groups of stem cells in cord blood and determining the point of clinical use.
Export Options
About this article
Cite this article as:
Cavusoglu Turker *, Kilic Dogan Kubilay , Yigitturk Gurkan , Tomruk Canberk , Turgut Mehmet and Uyanikgil Yigit , Clinical Use and Patentability of Cord Blood, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2017; 11 (1) . https://dx.doi.org/10.2174/1872214812666180314121241
DOI https://dx.doi.org/10.2174/1872214812666180314121241 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Role of microRNAs on Blood Brain Barrier Dysfunction in Vascular Cognitive Impairment
Current Drug Delivery Treatment Avenues for Type 2 Diabetes and Current Perspectives on Adipokines
Current Diabetes Reviews Proteomic Analysis of Liver Diseases: Molecular Mechanisms and Biomarker Discovery
Mini-Reviews in Medicinal Chemistry Celastrol Elicits Antitumor Effects through Inducing Immunogenic Cell Death and Downregulating PD-L1 in ccRCC
Current Pharmaceutical Design Non-peptide CRF-Receptor Antagonists: Allosterism, Kinetics and Translation to Efficacy in Human Disease
Current Molecular Pharmacology The Mouse In Cancer Research Past, Present, Future
Current Genomics Contribution of Electrochemistry to the Biomedical and Pharmaceutical Analytical Sciences
Current Drug Delivery Genomic Instability and Cancer
Current Molecular Medicine Novel Target Identification Technologies for the Personalised Therapy of Type II Diabetes and Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Perspectives On Membrane-associated Progesterone Receptors As Prospective Therapeutic Targets
Current Drug Targets Alternative Medicine Safety: Agaricus blazei and Propolis
Combinatorial Chemistry & High Throughput Screening Editorial (Hot Topic: Molecular Imaging Probes)
Current Organic Chemistry Exploring Optic Nerve Axon Regeneration
Current Neuropharmacology Nanoparticles, Promising Carriers in Drug Targeting: A Review
Current Drug Therapy Toxicogenomics to Improve Comprehension of the Mechanisms Underlying Responses of In Vitro and In Vivo Systems to Nanomaterials: A Review
Current Genomics Analysis of Organic Components Released from Dental Resin Composites in Saliva and Other Biological Fluids Using Chromatographic Techniques
Current Organic Chemistry Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents
Current Cancer Drug Targets Poly-Electrolyte Complex: A Novel System for Biomedical Applications and Recent Patents
Recent Patents on Nanotechnology Neuronal Differentiation of Neural Progenitor Cells by Intracellular Delivery of Synthetic Oligopeptide Derived from Von Hippel-Lindau Protein
Protein & Peptide Letters Relevance of Infertility, Epigenetics, Nutrient, and Bioactive Components: A Review of the Literature
Current Women`s Health Reviews